What Is Gout: Uric Acid, Triggers, Symptoms, and Management

A complete guide to gout covering uric acid metabolism, hyperuricemia, acute flare triggers, joint damage, and both pharmacological and dietary management strategies.

The InfoNexus Editorial TeamMay 10, 20259 min read

This article is for informational purposes only. Consult a qualified healthcare professional for medical advice, diagnosis, or treatment.

What Is Gout?

Gout is a form of inflammatory arthritis caused by the deposition of monosodium urate (MSU) crystals in joints and surrounding tissues. It is the most common inflammatory arthritis in men over 40 and is increasing in prevalence globally, now affecting approximately 4% of adults in the United States—about 9.2 million people. The condition has been documented for thousands of years; it was historically called the "disease of kings" because of its association with rich food and alcohol consumption, though it affects all socioeconomic groups today.

Uric Acid Metabolism and Crystal Formation

Uric acid is the end product of purine metabolism in humans. Purines are nitrogen-containing compounds found in all cells and in many foods, particularly organ meats, shellfish, and red meat. Unlike most mammals, humans lack the enzyme uricase, which breaks down uric acid into more soluble allantoin. As a result, uric acid must be excreted by the kidneys (70%) and intestines (30%).

When serum uric acid levels exceed approximately 6.8 mg/dL—the saturation point at body temperature—urate becomes supersaturated in the blood and synovial fluid. Over time, needle-shaped MSU crystals precipitate in the avascular environment of cartilage and the synovial fluid of peripheral joints, where temperature is slightly lower. The big toe's metatarsophalangeal joint is classically affected because it is the coolest and most peripheral joint in the body.

Stages of Gout

StageDescriptionDuration
Asymptomatic hyperuricemiaElevated uric acid without symptoms; crystals may be accumulating silentlyYears
Acute gout flareSudden onset intense joint pain, redness, swelling, warmth—often nocturnal3–10 days if untreated
Intercritical goutSymptom-free intervals between attacks; ongoing crystal depositionMonths to years
Chronic tophaceous goutPersistent tophi (crystal deposits) in soft tissue; chronic joint damagePermanent without treatment

Triggers of Acute Flares

Acute gout attacks are frequently triggered by events that cause rapid changes in serum uric acid levels—either sudden rises or sudden falls, which can dislodge existing crystals. Common precipitants include:

  • Dietary excess: Consumption of purine-rich foods (organ meats, anchovies, game meats) or high-fructose beverages raises uric acid production acutely.
  • Alcohol: Beer and spirits are the strongest alcohol triggers. Beer contains guanosine purines; all alcohol reduces renal uric acid excretion. Wine has a weaker association.
  • Dehydration: Concentrated urine raises urate levels; illness, surgery, or inadequate fluid intake commonly precipitate hospital-onset gout.
  • Medications: Thiazide and loop diuretics, low-dose aspirin, ciclosporin, and some anti-TB drugs (pyrazinamide, ethambutol) reduce urate excretion and raise serum uric acid.
  • Rapid uric acid-lowering therapy: Paradoxically, starting allopurinol or uricosuric drugs can mobilize crystal deposits and trigger flares during the first 3–6 months of treatment.
  • Trauma and surgery: Joint injury and the metabolic stress of surgery are well-recognized triggers.

Diagnosis

The gold standard for diagnosing gout is joint aspiration (arthrocentesis) with polarized light microscopy, which demonstrates negatively birefringent, needle-shaped MSU crystals within white blood cells. In practice, gout is often diagnosed clinically in patients with typical podagra (acute big-toe arthritis), hyperuricemia, and response to colchicine. Serum uric acid can be misleadingly normal or low during an acute attack due to increased renal excretion. Musculoskeletal ultrasound can detect the "double contour sign"—urate crystal deposition on cartilage—with good sensitivity.

Pharmacological Management

IndicationDrugMechanismKey Considerations
Acute flareColchicineInhibits neutrophil microtubule polymerizationMost effective within 24 hours of flare onset; GI side effects
Acute flareNSAIDs (indomethacin, naproxen)Inhibit prostaglandin synthesisAvoid in renal impairment; GI risk
Acute flareOral corticosteroidsBroad anti-inflammatoryUsed when NSAIDs/colchicine contraindicated
Urate-lowering (ULT)AllopurinolXanthine oxidase inhibitor; reduces uric acid productionFirst-line ULT; titrate to serum uric acid target <6 mg/dL
Urate-loweringFebuxostatXanthine oxidase inhibitor (non-purine)Alternative if allopurinol intolerant; cardiovascular monitoring needed
Urate-loweringProbenecidUricosuric; increases renal urate excretionAvoid in nephrolithiasis; requires adequate hydration
Flare prophylaxis during ULT initiationLow-dose colchicine or NSAIDSuppresses crystal-mobilization flaresRecommended for first 3–6 months of ULT

Dietary and Lifestyle Modifications

While diet alone rarely achieves sufficient uric acid lowering to eliminate gout, lifestyle changes reduce attack frequency and support medication effectiveness:

  • Limit purine-rich foods: organ meats, anchovies, sardines, mussels, game meats
  • Avoid or strictly limit alcohol, especially beer
  • Eliminate high-fructose corn syrup beverages (sodas, certain fruit juices)
  • Stay well hydrated—at least 2–3 liters of water daily to support renal urate excretion
  • Increase low-fat dairy consumption: associated with lower uric acid levels
  • Cherries and cherry extract have modest evidence for reducing flare frequency
  • Lose weight gradually if obese—rapid weight loss can paradoxically raise uric acid
  • Vitamin C supplementation (500 mg/day) modestly increases renal urate excretion

Long-Term Consequences if Untreated

Uncontrolled gout leads to progressive joint destruction, chronic pain, and reduced mobility. Tophi—chalky white deposits of MSU crystals visible beneath the skin—can form in the ears, elbows, fingers, and Achilles tendon. Gout is also independently associated with hypertension, cardiovascular disease, chronic kidney disease, and metabolic syndrome, making effective urate-lowering an important component of overall cardiometabolic risk management.

goutrheumatologyjoint health

Related Articles